Single oral dose study of GS 9256 in volunteers

Trial Profile

Single oral dose study of GS 9256 in volunteers

Phase of Trial: Phase I

Latest Information Update: 16 Feb 2011

At a glance

  • Drugs GS 9256 (Primary)
  • Indications Hepatitis C
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 16 Feb 2011 New trial record
    • 01 Nov 2010 Results presented at the 61st Annual Meeting of the American Association for the Study of Liver Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top